European Urology

Journal Abbreviation: EUR UROL
ISSN: 0302-2838
eISSN: 1873-7560
Publisher: Elsevier

Publications (46)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer (2024) Klümper N, Grünwald V, Hartmann A, Hölzel M, Eckstein M Journal article Re: Assessment of PD-L1, TROP2, and NECTIN-4 Expression in Penile Squamous Cell Carcinoma (2024) Linxweiler J, Klümper N, Mink J, Eckstein M, Junker K Journal article Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31, (S0302283823030737), (10.1016/j.eururo.2023.08.016)] (2024) Alfred Witjes J, Bruins HM, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, et al. Journal article, Erratum Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology (2024) Figiel S, Bates A, Braun DA, Eapen R, Eckstein M, Manley BJ, Milowsky MI, et al. Journal article, Review article Membranous expression of target protein is required for ADC response in urothelial cancer (2024) Klümper N, Brägelmann J, Bahlinger V, Hartmann A, Grünwald V, Kuppe C, Hölzel M, Eckstein M Journal article Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer (2024) Klümper N, Vera-Badillo FE, Eckstein M, Hadaschik B, Grünwald V Journal article Reply to Feng Qi's Letter to the Editor re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.04.026 (2024) Klümper N, Eckstein M Journal article Reply to Jon Griffin. TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer. Eur Urol. 2023;43:143–4 (2023) Klümper N, Hölzel M, Eckstein M Journal article European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines (2023) Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, et al. Journal article, Review article Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass) (2023) Grünwald V, Ivanyi P, Zschäbitz S, Wirth M, Staib P, Schostak M, Dargatz P, et al. Journal article